Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

SLS Relative to the S&P 500

SLS Relative to the Sector

Seasonal Chart Analysis

Analysis of the SELLAS Life Sciences Group, Inc. (NASD:SLS) seasonal charts above shows that a Buy Date of March 15 and a Sell Date of June 5 has resulted in a geometric average return of 1.3% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 101.3% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

To download SLS seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: SLS